Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News New research will target earliest stages of bone marrow cancer The opportunity to eradicate a major and incurable bone marrow cancer has been made possible with a new programme funded by Cancer Research UK.
News New research into autoimmune liver condition suggests unique cell movements may be driving disease
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
19 March 2024 Removal of incorrect penicillin allergy labels by non-specialist healthcare professional feasible 97% of patients who were deemed low risk and took part were assessed as not having allergy
12 March 2024 Future vaccine makers to get VR-assisted training centre of excellence University of Birmingham will lead UK-wide training to address critical skills demand in life sciences
04 March 2024 New research will target earliest stages of bone marrow cancer The opportunity to eradicate a major and incurable bone marrow cancer has been made possible with a new programme funded by Cancer Research UK.
02 February 2024 New research into autoimmune liver condition suggests unique cell movements may be driving disease A Birmingham study reveals a novel cellular phenomenon could be responsible for the onset of primary biliary cholangitis (PBC).
02 February 2024 Immune cells lose ‘killer instinct’ in cancerous tumours – but functionality can be re-awakened First study tracking how NK cells respond in tumours found that stimulating the IL-15 pathway prevented the rapid loss of function and improved tumour control
30 January 2024 New appointment: Dr Shivan Sivakumar Dr Shivan Sivakumar, a nationally recognised oncologist in cancers of the pancreas, liver and biliary tract, joins the College of Medical and Dental Sciences.
15 December 2023 Research Fellow receives five-year £706K Wellcome Trust Early-Career Award Dr Sally Clayton will study a novel pathway that becomes dysregulated in inflammatory diseases and how it controls the function in immune cells.